Paper20831742
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.
Schueler YB and 9 others. Acta Psychiatr Scand, 2011. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Papers, record 20831742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20831742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents, Tricyclic | Major topic |
| Cyclohexanols | Major topic |
| Major Depressive Disorder | Major topic |
| Thiophenes | Major topic |
| Adult | |
| Antidepressive Agents, Second-Generation | |
| Dose-Response Relationship, Drug | |
| Drug Resistance | |
| Duloxetine Hydrochloride | |
| Humans | |
| Pharmacological Phenomena | |
| Randomized Controlled Trials as Topic | |
| Remission Induction | |
| Therapeutic Equivalency | |
| Treatment Outcome | |
| Venlafaxine Hydrochloride |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42765056 | Venlafaxine for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster: Protocol for a Randomized Controlled Trial. | J Pain Res | 2026 | https://conductscience.org/library/papers/42765056 | PubMed |
| 41646204 | Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults. | Ment Health Clin | 2026 | https://conductscience.org/library/papers/41646204 | PubMed |
| 39440379 | The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. | Epidemiol Psychiatr Sci | 2024 | https://conductscience.org/library/papers/39440379 | PubMed |
| 37644009 | Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37644009 | PubMed |
| 36831876 | Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists. | Brain Sci | 2023 | https://conductscience.org/library/papers/36831876 | PubMed |
| 35947166 | Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine. | Psychopharmacology (Berl) | 2022 | https://conductscience.org/library/papers/35947166 | PubMed |
| 35815048 | Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults. | Front Psychiatry | 2022 | https://conductscience.org/library/papers/35815048 | PubMed |
| 34108032 | Duloxetine versus 'active' placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. | Syst Rev | 2021 | https://conductscience.org/library/papers/34108032 | PubMed |
| 31920318 | MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression. | Neuropsychiatr Dis Treat | 2019 | https://conductscience.org/library/papers/31920318 | PubMed |
| 30122927 | Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review. | Neuropsychiatr Dis Treat | 2018 | https://conductscience.org/library/papers/30122927 | PubMed |
| 29024974 | Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient. | Int J Neuropsychopharmacol | 2018 | https://conductscience.org/library/papers/29024974 | PubMed |
| 28677828 | Vortioxetine for depression in adults. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28677828 | PubMed |
| 26628045 | [Tricyclic antidepressants for initial treatment of depressive episodes? Pro]. | Nervenarzt | 2016 | https://conductscience.org/library/papers/26628045 | PubMed |
| 25037293 | A systematic approach to pharmacotherapy for geriatric major depression. | Clin Geriatr Med | 2014 | https://conductscience.org/library/papers/25037293 | PubMed |
| 24101861 | Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine. | Drug Des Devel Ther | 2013 | https://conductscience.org/library/papers/24101861 | PubMed |
| 23281074 | Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007. | Birth Defects Res A Clin Mol Teratol | 2013 | https://conductscience.org/library/papers/23281074 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20831742
GET https://conductscience.org/api/papers/v1/20831742/authors